Contrasting Dynatronics (DYNT) & PAVmed (PAVM)

Dynatronics (NASDAQ:DYNT) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, institutional ownership and profitability.

Valuation and Earnings

This table compares Dynatronics and PAVmed’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Dynatronics $64.42 million 0.21 -$1.60 million ($0.40) -3.95
PAVmed N/A N/A -$17.97 million N/A N/A

Dynatronics has higher revenue and earnings than PAVmed.

Insider and Institutional Ownership

12.3% of Dynatronics shares are held by institutional investors. Comparatively, 2.0% of PAVmed shares are held by institutional investors. 44.0% of Dynatronics shares are held by insiders. Comparatively, 29.2% of PAVmed shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

Dynatronics has a beta of -0.19, meaning that its stock price is 119% less volatile than the S&P 500. Comparatively, PAVmed has a beta of 0.25, meaning that its stock price is 75% less volatile than the S&P 500.

Profitability

This table compares Dynatronics and PAVmed’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Dynatronics -1.92% -12.65% -3.05%
PAVmed N/A -9,072.85% -119.06%

Analyst Ratings

This is a breakdown of recent ratings for Dynatronics and PAVmed, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics 0 0 2 0 3.00
PAVmed 0 0 1 0 3.00

Dynatronics currently has a consensus target price of $3.88, indicating a potential upside of 145.25%. PAVmed has a consensus target price of $3.00, indicating a potential upside of 180.37%. Given PAVmed’s higher probable upside, analysts plainly believe PAVmed is more favorable than Dynatronics.

Summary

Dynatronics beats PAVmed on 7 of the 10 factors compared between the two stocks.

Dynatronics Company Profile

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.

PAVmed Company Profile

PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.